NCT03984110View on ClinicalTrials.gov

One Year Trial Evaluating Safety of Ozurdex With Eylea

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

October 27, 2022

Study Completion Date

October 27, 2022

Conditions
Diabetic Macular Edema
Interventions
DRUG

Ozurdex

Intravitreal injection

DRUG

Eylea

Intravitreal injection

Trial Locations (1)

75231

Texas Retina Associates, Dallas

All Listed Sponsors
collaborator

The Emmes Company, LLC

INDUSTRY

lead

Texas Retina Associates

OTHER

NCT03984110 - One Year Trial Evaluating Safety of Ozurdex With Eylea | Biotech Hunter | Biotech Hunter